Hélène Cavé

Has grant

PUPH, Head of the molecular Genetics unit

Hôpital Robert-Debré

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hélène Cavé is an Associate Professor and Head of the Molecular Genetics Unit at Robert Debré Hospital and Université Paris-Cité in France. Her research focuses on pediatric acute lymphoblastic leukemia, including the genetic causes and clinical outcomes associated with this condition. She has contributed to various studies examining genetic subtypes of leukemia, genomic medicine integration in healthcare, and prognosis classifiers for juvenile myelomonocytic leukemia.

Recent Grants

Grant: Close

TRANSCALL 2 - TRANSlational research in Childhood Acute Lymphoblastic Leukemia 2

Open Date: 2018-04-01

Close Date: 2021-12-06

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (8)

Paul Kuentz

Professeur des Universités-Praticien Hospitalier

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

Richard Redon

INSERM

FRANCE

View details

Louise-Marie CHEVALIER

Institut de Cancérologie de l'Ouest

FRANCE

View details

Caroline Rooryck

University of Bordeaux

FRANCE

View details

Eric Pasmant

Head

Institut Curie

FRANCE

View details

Sarah Baer

Chief of resident

Hôpitaux universitaires de Strasbourg

FRANCE

View details

Pierre Vande Perre

Institut Claudius Regaud

FRANCE

View details

Doris Steinemann

Prof. Dr. rer. nat.

Medizinische Hochschule Hannover

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hélène Cavé

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome

Overt and covert genetic causes of pediatric acute lymphoblastic leukemia

Neurofibromatosis-Noonan syndrome: a prospective monocentric study of 26 patients and literature review

Two distinct fetal‐type signatures characterize juvenile myelomonocytic leukemia

CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL

Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Outcomes of infants with very late relapse of acute lymphoblastic leukaemia initially treated in Interfant‐06

Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.

Collaborators (8)

Paul Kuentz

Richard Redon

Louise-Marie CHEVALIER

Caroline Rooryck

Eric Pasmant

Sarah Baer

Pierre Vande Perre

Doris Steinemann

Make your next move.

Hélène Cavé

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

&lt;i&gt;PFMG2025&lt;/i&gt;-integrating genomic medicine into the national healthcare system in France.

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome

Overt and covert genetic causes of pediatric acute lymphoblastic leukemia

Neurofibromatosis-Noonan syndrome: a prospective monocentric study of 26 patients and literature review

Two distinct fetal‐type signatures characterize juvenile myelomonocytic leukemia

CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL

Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B‐ and T‐cell acute lymphoblastic leukemia

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.

Outcomes of infants with very late relapse of acute lymphoblastic leukaemia initially treated in Interfant‐06

Differential activation of basal and IL-7-induced PI3K/Akt/ mTOR and JAK/STAT5 signaling distinguishes pediatric from adult acute lymphoblastic leukemia.

Collaborators (8)

Paul Kuentz

Richard Redon

Louise-Marie CHEVALIER

Caroline Rooryck

Eric Pasmant

Sarah Baer

Pierre Vande Perre

Doris Steinemann

Make your next move.

<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.